The Europe Anti-Snoring Devices Market would witness market growth of 7.1% CAGR during the forecast period (2023-2030).
The risk of obesity-related problems like coronary artery disease (CAD) as well as end-stage renal disease is significantly increased in men who are severely obese. For example, in America, the overall incidence of obesity in men aged 20 to 39 was 40.3%, that in men aged 40 to 59 was 46.4%, and that in men aged 60 and above was 42.2%. Similarly, in the United Kingdom, 1 in 4 people and 2 out of 3 men are obese.
Leading factors influencing the growth of this market include the rising prevalence of obesity, the introduction of technologically sophisticated products, strategic actions taken by leading market participants, and the ease with which items can be obtained through both online and offline channels. Additionally, the introduction and regulatory approval of new goods over the past two years have contributed to the recovery and helped the market expand dramatically. Many clients are also migrating toward E-commerce due to the rapid growth of technology. The demand will continue to rise due to the availability of various devices on e-commerce websites. With the advent of technology, four major types of medical e-business exist, namely online pharmacies, retailers of medical supplies and equipment, telemedicine portals, and healthcare sectors.
According to estimations, 52.7% of adults in the EU were overweight in 2019. Weight issues and obesity are rising quickly in most EU Member States. The percentage of overweight adults varied from 37% in Italy to 58% in Croatia for women and from 53% in France to 73% in Croatia for men. Obesity is an important public health issue because it raises the risk of snoring along with several chronic diseases, including heart disease, type 2 diabetes, coronary heart disease, hypertension, and some types of cancer. Obesity may also be related to various psychological issues for particular people. Therefore, the region presents lucrative growth opportunities for the market.
The Germany market dominated the Europe Anti-Snoring Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $26.2 Million by 2030. The UK market is showcasing a CAGR of 6.2% during (2023 - 2030). Additionally, The France market would experience a CAGR of 7.9% during (2023 - 2030).
Based on End User, the market is segmented into Homecare, and Others. Based on Product, the market is segmented into Mouthguard (Mandibular Advancement Devices, and Tongue Retaining Device), Nasal Devices, EPAP Device, and Others. The report also covers geographical segmentation of Anti-Snoring Devices market. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Anti-Snoring Devices Market is Projected to reach USD 403.6 Million by 2030, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., ResMed, Inc., SomnoMed Limited, The Pure Sleep Company, TAP Sleep Care, VVFLY Electronics Co., Ltd., Apnea Sciences Corporation, ZQuiet (Sleeping Well, LLC), and DentCare Dental Lab Pvt. Ltd.
By End User
By Product
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
